359 related articles for article (PubMed ID: 34093595)
1. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Brand I; Gilberg L; Bruger J; Garí M; Wieser A; Eser TM; Frese J; Ahmed MIM; Rubio-Acero R; Guggenbuehl Noller JM; Castelletti N; Diekmannshemke J; Thiesbrummel S; Huynh D; Winter S; Kroidl I; Fuchs C; Hoelscher M; Roider J; Kobold S; Pritsch M; Geldmacher C
Front Immunol; 2021; 12():688436. PubMed ID: 34093595
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
Echeverría G; Guevara Á; Coloma J; Ruiz AM; Vasquez MM; Tejera E; de Waard JH
Int J Infect Dis; 2021 Apr; 105():21-25. PubMed ID: 33582369
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
4. Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination.
Fernández-González M; Agulló V; Padilla S; García JA; García-Abellán J; Botella Á; Mascarell P; Ruiz-García M; Masiá M; Gutiérrez F
Clin Infect Dis; 2022 Aug; 75(1):e338-e346. PubMed ID: 34893816
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort.
Barreiro P; Sanz JC; San Román J; Pérez-Abeledo M; Carretero M; Megías G; Viñuela-Prieto JM; Ramos B; Canora J; Martínez-Peromingo FJ; Barba R; Zapatero A; Candel FJ
J Clin Microbiol; 2022 Mar; 60(3):e0219921. PubMed ID: 35020419
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM; Havervall S; Laurén I; Lindsay R; Jernbom Falk A; Marking U; Lord M; Buggert M; Dönnes P; Christoffersson G; Nilsson P; Hober S; Phillipson M; Klingström J; Thålin C
PLoS One; 2021; 16(9):e0258041. PubMed ID: 34591918
[TBL] [Abstract][Full Text] [Related]
8. Rapid Cytokine Release Assays for Analysis of Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells in Whole Blood.
Törnell A; Grauers Wiktorin H; Ringlander J; Arabpour M; Nilsson MR; Nilsson S; Kiffin R; Lindh M; Lagging M; Hellstrand K; Martner A
J Infect Dis; 2022 Aug; 226(2):208-216. PubMed ID: 35022764
[TBL] [Abstract][Full Text] [Related]
9. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients.
Mohn KG; Bredholt G; Zhou F; Madsen A; Onyango TB; Fjelltveit EB; Jalloh SL; Brokstad KA; Cantoni D; Mayora-Neto M; Temperton N; Langeland N; Cox RJ;
PLoS One; 2022; 17(2):e0261979. PubMed ID: 35192617
[TBL] [Abstract][Full Text] [Related]
10. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
[TBL] [Abstract][Full Text] [Related]
12. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
Marklund E; Leach S; Nyström K; Lundgren A; Liljeqvist JÅ; Nilsson S; Yilmaz A; Andersson LM; Bemark M; Gisslén M
Front Immunol; 2021; 12():750448. PubMed ID: 34795668
[TBL] [Abstract][Full Text] [Related]
14. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave.
Aiello A; Grossi A; Meschi S; Meledandri M; Vanini V; Petrone L; Casetti R; Cuzzi G; Salmi A; Altera AM; Pierelli L; Gualano G; Ascoli Bartoli T; Castilletti C; Agrati C; Girardi E; Palmieri F; Nicastri E; Di Rosa E; Goletti D
Front Immunol; 2022; 13():920227. PubMed ID: 35967321
[TBL] [Abstract][Full Text] [Related]
15. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
16. Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workers.
Martínez-Gallo M; Esperalba J; Pujol-Borrell R; Sandá V; Arrese-Muñoz I; Fernández-Naval C; Antón A; Cardona V; Labrador-Horrillo M; Pumarola T; Hernandéz-González M
Med Clin (Barc); 2022 Aug; 159(3):116-123. PubMed ID: 34666900
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
Front Immunol; 2021; 12():748291. PubMed ID: 34867975
[TBL] [Abstract][Full Text] [Related]
18. SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study.
Casado JL; Häemmerle J; Vizcarra P; Velasco H; Velasco T; Fernandez-Escribano M; Vallejo A
Clin Microbiol Infect; 2021 Jun; 27(6):916.e1-916.e4. PubMed ID: 33667629
[TBL] [Abstract][Full Text] [Related]
19. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
[TBL] [Abstract][Full Text] [Related]
20. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
